Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

112 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-24

Study Completion Date

2021-01-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, pulmonary embolism,…). It is therefore necessary to provide a framework for the follow up of patients. Moreover SARS-CoV-2 infection consequences remain unknow at this time. Study hypothesis is that COVID alters determining factors (physical or psychological) of quality of life after ICU hospitalisation. The aim of the study is to assess quality of life 3 months after ICU hospitalization.

Secondary purposes of the study are 1) assessment of quality of life 6 months and the evolution between the third and the sixth months after ICU hospitalization 2) description patients care after 3 and 6 months ICU left and their clinical status 3) convening and providing a "platform" within several physicians (neurologist, biologist, pneumologist…) will be able to follow up patients and perform complementary investigations according to patients injuries.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PREdiction of DIagnosed Covid-19 infecTion in IUC Patients

NCT04327180

Infection Viral Coronavirus ARDS +1 more

COMPLETED

Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic

NCT04438941

Sars-CoV2

UNKNOWN

Consequences in ICU of Vaccination Status of Covid-19 Patients

NCT06191341

SARS CoV 2 Infection

COMPLETED

One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

NCT04401111

COVID ARDS Quality of Life

RECRUITING

Study in Intensive Care Follow-up Programme in Improving Long-term Outcomes of ICU Survivors

NCT01796509

Quality of Life Post ICU Discharge

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Follow up Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

quality of live assessment

quality of live assessment 3 moth and 6 moth after ointensive care hospitalisation using SF36.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject male or female ≥ 18 years old
* Patient hospitalized in the anesthesia-resuscitation department of the NHC for COVID-19 from March 1, 2020.
* Patient (or his legal representative) having given his consent for the use of his data for the purposes of this research.

Exclusion Criteria

* Subject not hospitalized in intensive care
* Patient's refusal to participate in the study
* Inability to give informed information to the subject (subject in an emergency, difficulty understanding the subject, etc.)
* Subject under low protection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes